Ipopema Benefit 3 Fizan (WSE:IPOBENE3U) - Stock Price, News & Analysis

IPOBENE3U Stock Overview

No business description

No updates

No updates

	IPOBENE3U	PL Capital Markets	PL Market
7D	0%	0.5%	3.1%
1Y	10.0%	47.3%	22.8%

Return vs Industry: IPOBENE3U underperformed the Polish Capital Markets industry which returned 20.4% over the past year.

Return vs Market: IPOBENE3U underperformed the Polish Market which returned 24.7% over the past year.

Is IPOBENE3U's price volatile compared to industry and market?
IPOBENE3U volatility
IPOBENE3U Average Weekly Movement	n/a
Capital Markets Industry Average Movement	5.7%
Market Average Movement	5.2%
10% most volatile stocks in PL Market	9.1%
10% least volatile stocks in PL Market	3.3%

Stable Share Price: IPOBENE3U has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine IPOBENE3U's volatility change over the past year.

Founded	Employees	CEO	Website
n/a	n/a	n/a	n/a

How do Ipopema Benefit 3 Fizan's earnings and revenue compare to its market cap?
IPOBENE3U fundamental statistics
Market cap	n/a
Earnings (TTM)	zł0
Revenue (TTM)	n/a

P/E Ratio

P/S Ratio

Is IPOBENE3U overvalued?

Key profitability statistics from the latest earnings report (TTM)
IPOBENE3U income statement (TTM)
Revenue	zł0
Cost of Revenue	zł0
Gross Profit	zł0
Other Expenses	zł0
Earnings	zł0

Last Reported Earnings

n/a

Next Earnings Date

n/a

How did IPOBENE3U perform over the long term?